glp-1 receptor agonists GLP-1 receptor agonists for individualized

[Google Scholar] 13.Pi-Sunyer X., Astrup A., Fujioka K., Greenway F., Halpern A., Krempf M., Lau D.C., le Roux C.W., Violante Ortiz R., Jensen C.B., et al

Originally developed for diabetes, GLP-1RAs have become a lifeline for millions seeking effective, sustainable weight loss solutions.

These medications have resulted in HbA1c reductions ranging from 0.8% to 1.8% in clinical trials [55]

GLP-1s show great results but work best for weight management as part of a comprehensive program that combines a nutritious diet, appropriate levels of exercise, healthy amounts of sleep, and stress management

These agents mimic the biological action of the native incretin hormone GLP-1 but are structurally modified to resist degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), thereby extending their half-life and duration of action (Zheng et al., 2024